RUNX3 controls a metastatic switch in pancreatic ductal adenocarcinoma

For the majority of patients with pancreas cancer, the high metastatic proclivity is life-limiting. Some patients, however, present with and succumb to locally destructive disease. A molecular understanding of these distinct disease manifestations can critically inform patient management. Using gene...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell
Autors principals: Whittle, Martin C., Izeradjene, Kamel, Rani, P. Geetha, Feng, Libing, Carlson, Markus A., DelGiorno, Kathleen E., Wood, Laura D., Goggins, Michael, Hruban, Ralph H., Chang, Amy E., Calses, Philamer, Thorsen, Shelley M., Hingorani, Sunil R.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4458240/
https://ncbi.nlm.nih.gov/pubmed/26004068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cell.2015.04.048
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars